Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa

Nature Reviews Microbiology

Volumn 10, Issue 1, 2012, Pages 66-78

  Bron, Peter A ^a,b,c   Van Baarlen, Peter ^d   Kleerebezem, Michiel ^a,b,d  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b NIZO FOOD RESEARCH   (Netherlands)

^c KLUYVER CENTRE FOR GENOMICS OF INDUSTRIAL FERMENTATION   (Netherlands)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; BACTERIOCIN; CD209 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; PEPTIDOGLYCAN; PROBIOTIC AGENT; TEICHOIC ACID; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; GENETIC VARIABILITY; GRAM POSITIVE BACTERIUM; HOMEOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; MOLECULAR INTERACTION; MUCOSAL IMMUNITY; NONHUMAN; NUTRIGENOMICS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; RISK REDUCTION; SIGNAL TRANSDUCTION;

BACTERIA; HUMANS; IMMUNOLOGIC FACTORS; INTESTINAL MUCOSA; PROBIOTICS;

BACTERIA (MICROORGANISMS);

EID: 83855165652     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro2690     Document Type: Review

References (173)

1. Food and Agriculture Organization-WHO. Guidelines for the evaluation of probiotics in food. (WHO, London, Ontario, 2002).
2. Kleerebezem, M. et al. The extracellular biology of the lactobacilli. FEMS Microbiol. Rev. 34, 199-230 (2010).
3. Gordon, S. Elie Metchnikoff: father of natural immunity. Eur. J. Immunol. 38, 3257-3264 (2008).
4. Metchnikoff, É. The Prolongation of Life: Optimistic Studies (ed. Mitchell, P. C.) (Heinemann, London, 1907).
5. Tissier, H. Des infections intestinales par la méthode de la flore bactérienne de l'intestin. Crit. Rev. Soc. Biol. 60, 359-361 (1906) (in French).
6. Lebeer, S., Vanderleyden, J. & De Keersmaecker, S. C. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nature Rev. Microbiol. 8, 171-184 (2010).
7. Marco, M. L., Pavan, S. & Kleerebezem, M. Towards understanding molecular modes of probiotic action. Curr. Opin. Biotechnol. 17, 204-210 (2006).
8. Do, V. T., Baird, B. G. & Kockler, D. R. Probiotics for maintaining remission of ulcerative colitis in adults. Ann. Pharmacother. 44, 565-571 (2010).
9. Trebichavsky, I., Splichal, I., Rada, V. & Splichalova, A. Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917. Nutr. Rev. 68, 459-464 (2010).
10. Alfaleh, K., Anabrees, J. & Bassler, D. Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: a meta-analysis. Neonatology 97, 93-99 (2010).
11. Deshpande, G., Rao, S., Patole, S. & Bulsara, M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125, 921-930 (2010).
12. Kale-Pradhan, P. B., Jassal, H. K. & Wilhelm, S. M. Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis. Pharmacotherapy 30, 119-126 (2010).
13. Holubar, S. D., Cima, R. R., Sandborn, W. J. & Pardi, D. S. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst. Rev. 2010, CD001176 (2010).
14. Boyle, R. J., Bath-Hextall, F. J., Leonardi-Bee, J., Murrell, D. F. & Tang, M. L. Probiotics for the treatment of eczema: a systematic review. Clin. Exp. Allergy 39, 1117-1127 (2009).
15. Rioux, K. P. & Fedorak, R. N. Probiotics in the treatment of inflammatory bowel disease. J. Clin. Gastroenterol. 40, 260-263 (2006).
16. Moayyedi, P. et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 59, 325-332 (2010).
17. Borchers, A. T., Selmi, C., Meyers, F. J., Keen, C. L. & Gershwin, M. E. Probiotics and immunity. J. Gastroenterol. 44, 26-46 (2009).
18. Pelto, L., Isolauri, E., Lilius, E. M., Nuutila, J. & Salminen, S. Probiotic bacteria downregulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin. Exp. Allergy 28, 1474-1479 (1998).
19. Roessler, A. et al. The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention. Clin. Exp. Allergy 38, 93-102 (2008).
20. Lebeer, S., Vanderleyden, J. & De Keersmaecker, S. C. Genes and molecules of lactobacilli supporting probiotic action. Microbiol. Mol. Biol. Rev. 72, 728-764 (2008).
21. Corr, S. C., Hill, C. & Gahan, C. G. Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. Adv. Food Nutr. Res. 56, 1-15 (2009).
22. Mack, D. R., Ahrne, S., Hyde, L., Wei, S. & Hollingsworth, M. A. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52, 827-833 (2003).
23. Schlee, M. et al. Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2. Clin. Exp. Immunol. 151, 528-535 (2008).
24. Schlee, M. et al. Induction of human β-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect. Immun. 75, 2399-2407 (2007).
25. Yan, F. et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562-575 (2007).
26. Yan, F. & Polk, D. B. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J. Biol. Chem. 277, 50959-50965 (2002).
27. Anderson, R. C. et al. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol. 10, 316 (2010).
28. Karczewski, J. et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G851-G859 (2010).
29. Seth, A., Yan, F., Polk, D. B. & Rao, R. K. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC-and MAP kinase-dependent mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G1060-G1069 (2008).
30. O'Flaherty, S., Saulnier, D. M., Pot, B. & Versalovic, J. How can probiotics and prebiotics impact mucosal immunity? Gut Microbes 1, 293-300 (2010).
31. Booijink, C. C. et al. High temporal and inter-individual variation detected in the human ileal microbiota. Environ. Microbiol. 12, 3213-3227 (2010).
32. Booijink, C. C., Zoetendal, E. G., Kleerebezem, M. & de Vos, W. M. Microbial communities in the human small intestine: coupling diversity to metagenomics. Future Microbiol. 2, 285-295 (2007).
33. Fukuda, S. et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543-547 (2011).
34. Maslowski, K. M. et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282-1286 (2009).
35. Veiga, P. et al. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc. Natl Acad. Sci. USA 107, 18132-18137 (2010).
36. O'Hara, A. M. et al. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 118, 202-215 (2006).
37. Balda, M. S. & Matter, K. Tight junctions at a glance. J. Cell Sci. 121, 3677-3682 (2008).
38. McCracken, V. J. & Lorenz, R. G. The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell. Microbiol. 3, 1-11 (2001).
39. Bevins, C. L. & Salzman, N. H. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nature Rev. Microbiol. 9, 356-368 (2011).
40. Salzman, N. H. Microbiota-immune system interaction: an uneasy alliance. Curr. Opin. Microbiol. 14, 99-105 (2011).
41. Wells, J. M., Rossi, O., Meijerink, M. & van Baarlen, P. Epithelial crosstalk at the microbiota-mucosal interface. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4607-4614 (2011).
42. Liew, F. Y. TH1 and TH2 cells: a historical perspective. Nature Rev. Immunol. 2, 55-60 (2002).
43. Barnes, M. J. & Powrie, F. Regulatory T cells reinforce intestinal homeostasis. Immunity 31, 401-411 (2009).
44. Kelsall, B. Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages. Mucosal Immunol. 1, 460-469 (2008).
45. Rescigno, M. Intestinal dendritic cells. Adv. Immunol. 107, 109-138 (2010).
46. Coombes, J. L. & Powrie, F. Dendritic cells in intestinal immune regulation. Nature Rev. Immunol. 8, 435-446 (2008).
47. Kapsenberg, M. L. Dendritic-cell control of pathogen-driven T-cell polarization. Nature Rev. Immunol. 3, 984-993 (2003).
48. Sansonetti, P. J. & Medzhitov, R. Learning tolerance while fighting ignorance. Cell 138, 416-420 (2009).
49. Chung, H. & Kasper, D. L. Microbiota-stimulated immune mechanisms to maintain gut homeostasis. Curr. Opin. Immunol. 22, 455-460 (2010).
50. Lee, Y. K. & Mazmanian, S. K. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330, 1768-1773 (2010).
51. Artis, D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nature Rev. Immunol. 8, 411-420 (2008).
52. Gaboriau-Routhiau, V. et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689 (2009).
53. Sartor, R. B. Therapeutic correction of bacterial dysbiosis discovered by molecular techniques. Proc. Natl Acad. Sci. USA 105, 16413-16414 (2008).
54. Reid, G. et al. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nature Rev. Microbiol. 9, 27-38 (2011).
55. Asong, J., Wolfert, M. A., Maiti, K. K., Miller, D. & Boons, G. J. Binding and cellular activation studies reveal that Toll-like receptor 2 can differentially recognize peptidoglycan from Gram-positive and Gram-negative bacteria. J. Biol. Chem. 284, 8643-8653 (2009).
56. Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21, 335-376 (2003).
57. Dziarski, R. & Gupta, D. Staphylococcus aureus peptidoglycan is a Toll-like receptor 2 activator: a reevaluation. Infect. Immun. 73, 5212-5216 (2005).
58. Travassos, L. H. et al. Toll-like receptor 2 dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 5, 1000-1006 (2004).
59. Volz, T. et al. Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent co-stimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J. 24, 4089-4102 (2010).
60. Macho Fernandez, E. et al. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2 mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60, 1050-1059 (2011).
61. Delcour, J., Ferain, T., Deghorain, M., Palumbo, E. & Hols, P. The biosynthesis and functionality of the cell-wall of lactic acid bacteria. Antonie Van Leeuwenhoek 76, 159-184 (1999).
62. Foligne, B. et al. A key role of dendritic cells in probiotic functionality. PLoS ONE 2, e313 (2007).
63. Zeuthen, L. H., Fink, L. N. & Frokiaer, H. Toll-like receptor 2 and nucleotide-binding oligomerization domain 2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells. Immunology 124, 489-502 (2008).
64. Xia, G., Kohler, T. & Peschel, A. The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. Int. J. Med. Microbiol. 300, 148-154 (2010).
65. Grangette, C. et al. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl Acad. Sci. USA 102, 10321-10326 (2005).
66. Kim, H. G. et al. Inhibitory effects of Lactobacillus plantarum lipoteichoic acid (LTA) on Staphylococcus aureus LTA-induced tumour necrosis factor-alpha production. J. Microbiol. Biotechnol. 18, 1191-1196 (2008).
67. Matsuguchi, T. et al. Lipoteichoic acids from Lactobacillus strains elicit strong tumour necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin. Diagn. Lab. Immunol. 10, 259-266 (2003).
68. Mohamadzadeh, M. et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4623-4630 (2011).
69. Saber, R. et al. Lipoteichoic acid-deficient Lactobacillus acidophilus regulates downstream signals. Immunotherapy 3, 337-347 (2011).
70. Hirose, Y. et al. Lipoteichoic acids on Lactobacillus plantarum cell surfaces correlate with induction of interleukin 12p40 production. Microbiol. Immunol. 54, 143-151 (2010).
71. Perea Velez, M. et al. Functional analysis of d alanylation of lipoteichoic acid in the probiotic strain Lactobacillus rhamnosus GG. Appl. Environ. Microbiol. 73, 3595-3604 (2007).
72. Kaji, R., Kiyoshima-Shibata, J., Nagaoka, M., Nanno, M. & Shida, K. Bacterial teichoic acids reverse predominant IL-12 production induced by certain Lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J. Immunol. 184, 3505-3513 (2010).
73. Ryu, Y. H. et al. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. Int. Immunopharmacol. 9, 127-133 (2009).
74. Jang, K. S., Baik, J. E., Han, S. H., Chung, D. K. & Kim, B. G. Multi-spectrometric analyses of lipoteichoic acids isolated from Lactobacillus plantarum. Biochem. Biophys. Res. Commun. 407, 823-830 (2011).
75. Claes, I. J. et al. Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis. Clin. Exp. Immunol. 162, 306-314 (2010).
76. Wang, Q. et al. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J. Exp. Med. 203, 2853-2863 (2006).
77. Rockel, C., Hartung, T. & Hermann, C. Different Staphylococcus aureus whole bacteria mutated in putative pro-inflammatory membrane components have similar cytokine inducing activity. Immunobiology 216, 316-321 (2011).
78. Yasuda, E., Serata, M. & Sako, T. Suppressive effect on activation of macrophages by Lactobacillus casei strain Shirota genes determining the synthesis of cell wall-associated polysaccharides. Appl. Environ. Microbiol. 74, 4746-4755 (2008).
79. Hafez, M. et al. The K5 capsule of Escherichia coli strain Nissle 1917 is important in mediating interactions with intestinal epithelial cells and chemokine induction. Infect. Immun. 77, 2995-3003 (2009).
80. Lebeer, S. et al. Identification of a gene cluster for the biosynthesis of a long, galactose-rich exopolysaccharide in Lactobacillus rhamnosus GG and functional analysis of the priming glycosyltransferase. Appl. Environ. Microbiol. 75, 3554-3563 (2009).
81. Lebeer, S., Claes, I. J., Verhoeven, T. L., Vanderleyden, J. & De Keersmaecker, S. C. Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine. Microb. Biotechnol. 4, 368-374 (2011).
82. Pilobello, K. T. & Mahal, L. K. Deciphering the glycocode: the complexity and analytical challenge of glycomics. Curr. Opin. Chem. Biol. 11, 300-305 (2007).
83. Xia, G. et al. Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM. J. Biol. Chem. 285, 13405-13415 (2010).
84. Vollmer, W. Structural variation in the glycan strands of bacterial peptidoglycan. FEMS Microbiol. Rev. 32, 287-306 (2008).
85. Tomita, S. et al. Comparison of components and synthesis genes of cell wall teichoic acid among Lactobacillus plantarum strains. Biosci. Biotechnol. Biochem. 74, 928-933 (2010).
86. Francius, G. et al. Detection, localization, and conformational analysis of single polysaccharide molecules on live bacteria. ACS Nano 2, 1921-1929 (2008).
87. Marco, M. L. et al. Convergence in probiotic Lactobacillus gut-adaptive responses in humans and mice. ISME J. 4, 1481-1484 (2010).
88. Andre, G. et al. Fluorescence and atomic force microscopy imaging of wall teichoic acids in Lactobacillus plantarum. ACS Chem. Biol. 6, 366-376 (2011).
89. Atilano, M. L. et al. Teichoic acids are temporal and spatial regulators of peptidoglycan crosslinking in Staphylococcus aureus. Proc. Natl Acad. Sci. USA 107, 18991-18996 (2010).
90. Ventura, M. et al. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nature Rev. Microbiol. 7, 61-71 (2009).
91. Smits, H. H. et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 115, 1260-1267 (2005).
92. Konstantinov, S. R. et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl Acad. Sci. USA 105, 19474-19479 (2008).
93. Johnson-Henry, K. C., Hagen, K. E., Gordonpour, M., Tompkins, T. A. & Sherman, P. M. Surface-layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells. Cell. Microbiol. 9, 356-367 (2007).
94. Corr, S. C. et al. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl Acad. Sci. USA 104, 7617-7621 (2007).
95. Molenaar, D. et al. Exploring Lactobacillus plantarum genome diversity by using microarrays. J. Bacteriol. 187, 6119-6127 (2005).
96. Siezen, R. J. et al. Phenotypic and genomic diversity of Lactobacillus plantarum strains isolated from various environmental niches. Environ. Microbiol. 12, 758-773 (2010).
97. van Haemert, S. et al. Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells. BMC Microbiol. 10, 293 (2010).
98. Meijerink, M. et al. Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization. PLoS ONE 5, e10632 (2010).
99. Bron, P. A., Grangette, C., Mercenier, A., de Vos, W. M. & Kleerebezem, M. Identification of Lactobacillus plantarum genes that are induced in the gastrointestinal tract of mice. J. Bacteriol. 186, 5721-5729 (2004).
100. Marco, M. L., Bongers, R. S., de Vos, W. M. & Kleerebezem, M. Spatial and temporal expression of Lactobacillus plantarum genes in the gastrointestinal tracts of mice. Appl. Environ. Microbiol. 73, 124-132 (2007).
101. Marco, M. L. et al. Lifestyle of Lactobacillus plantarum in the mouse caecum. Environ. Microbiol. 11, 2747-2757 (2009).
102. Pretzer, G. et al. Biodiversity-based identification and functional characterization of the mannose-specific adhesin of Lactobacillus plantarum. J. Bacteriol. 187, 6128-6136 (2005).
103. Gross, G. et al. Mannose-specific interaction of Lactobacillus plantarum with porcine jejunal epithelium. FEMS Immunol. Med. Microbiol. 54, 215-223 (2008).
104. Bauerl, C., Perez-Martinez, G., Yan, F., Polk, D. B. & Monedero, V. Functional analysis of the p40 and p75 proteins from Lactobacillus casei BL23. J. Mol. Microbiol. Biotechnol. 19, 231-241 (2010).
105. Yan, F. et al. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J. Clin. Invest. 121, 2242-2253 (2011).
106. Abu-Qarn, M., Eichler, J. & Sharon, N. Not just for Eukarya anymore: protein glycosylation in Bacteria and Archaea. Curr. Opin. Struct. Biol. 18, 544-550 (2008).
107. Cario, E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut 54, 1182-1193 (2005).
108. Cario, E., Gerken, G. & Podolsky, D. K. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127, 224-238 (2004).
109. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
110. Resta-Lenert, S. & Barrett, K. E. Probiotics and commensals reverse TNF α and IFN γ induced dysfunction in human intestinal epithelial cells. Gastroenterology 130, 731-746 (2006).
111. Ulluwishewa, D. et al. Regulation of tight junction permeability by intestinal bacteria and dietary components. J. Nutr. 141, 769-776 (2011).
112. Mangell, P. et al. Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability. Dig. Dis. Sci. 47, 511-516 (2002).
113. Qin, H., Zhang, Z., Hang, X. & Jiang, Y. L. plantarum prevents Enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol. 9, 63 (2009).
114. Troost, F. J. et al. Identification of the transcriptional response of human intestinal mucosa to Lactobacillus plantarum WCFS1 in vivo. BMC Genomics 9, 374 (2008).
115. Mao, Y. et al. The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 111, 334-344 (1996).
116. White, J. S. et al. The probiotic bacterium Lactobacillus plantarum species 299 reduces intestinal permeability in experimental biliary obstruction. Lett. Appl. Microbiol. 42, 19-23 (2006).
117. Christensen, H. R., Frokiaer, H. & Pestka, J. J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168, 171-178 (2002).
118. Drakes, M., Blanchard, T. & Czinn, S. Bacterial probiotic modulation of dendritic cells. Infect. Immun. 72, 3299-3309 (2004).
119. Gately, M. K. et al. The interleukin-12/interleukin-12 receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16, 495-521 (1998).
120. Mohamadzadeh, M. et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc. Natl Acad. Sci. USA 102, 2880-2885 (2005).
121. Foligne, B. et al. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J. Gastroenterol. 13, 236-243 (2007).
122. Latvala, S. et al. Potentially probiotic bacteria induce efficient maturation but differential cytokine production in human monocyte-derived dendritic cells. World J. Gastroenterol. 14, 5570-5583 (2008).
123. Niers, L. E. et al. Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells. Clin. Exp. Immunol. 149, 344-352 (2007).
124. Vissers, Y. M. et al. Lactobacillus strains differentially modulate cytokine production by hPBMC from pollen-allergic patients. FEMS Immunol. Med. Microbiol. 61, 28-40 (2011).
125. Peran, L. et al. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J. Gastroenterol. 11, 5185-5192 (2005).
126. Zoumpopoulou, G. et al. Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulphonic acid (TNBS)-induced colitis and Salmonella infection in murine models. Int. J. Food Microbiol. 121, 18-26 (2008).
127. Roselli, M. et al. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of γδT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm. Bowel Dis. 15, 1526-1536 (2009).
128. Kwon, H. K. et al. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc. Natl Acad. Sci. USA 107, 2159-2164 (2010).
129. Mileti, E., Matteoli, G., Iliev, I. D. & Rescigno, M. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS ONE 4, e7056 (2009).
130. Di Caro, S. et al. The European experience with double-balloon enteroscopy: indications, methodology, safety, and clinical impact. Gastrointest. Endosc. 62, 545-550 (2005).
131. Van Baarlen, P. et al. Differential NF κB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc. Natl Acad. Sci. USA 106, 2371-2376 (2009).
132. Van Baarlen, P. et al. Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4562-4569 (2011).
133. Kalliomaki, M. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076-1079 (2001).
134. Kalliomaki, M., Salminen, S., Poussa, T., Arvilommi, H. & Isolauri, E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361, 1869-1871 (2003).
135. Kalliomaki, M. & Isolauri, E. Role of intestinal flora in the development of allergy. Curr. Opin. Allergy Clin. Immunol. 3, 15-20 (2003).
136. Schultz, M. et al. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J. Dairy Res. 70, 165-173 (2003).
137. Gilliland, S. E. Acidophilus milk products: a review of potential benefits to consumers. J. Dairy Sci. 72, 2483-2494 (1989).
138. Gill, H. S., Rutherfurd, K. J., Prasad, J. & Gopal, P. K. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr. 83, 167-176 (2000).
139. Paturi, G., Phillips, M. & Kailasapathy, K. Effect of probiotic strains Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 on systemic immune functions and bacterial translocation in mice. J. Food Prot. 71, 796-801 (2008).
140. Weiss, G. et al. Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism. Immunology 131, 268-281 (2010).
141. Bloksma, N., de Heer, E., Van Dijk, H. & Willers, J. M. Adjuvanticity of lactobacilli. I. Differential effects of viable and killed bacteria. Clin. Exp. Immunol. 37, 367-375 (1979).
142. Bloksma, N., Van Dijk, H., Korst, P. & Willers, J. M. Cellular and humoral adjuvant activity of mistletoe extract. Immunobiology 156, 309-318 (1979).
143. Heinzerling, L., von Baehr, V., Liebenthal, C., von Baehr, R. & Volk, H. D. Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo. J. Clin. Immunol. 26, 347-359 (2006).
144. Karlsson, H., Hessle, C. & Rudin, A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect. Immun. 70, 6688-6696 (2002).
145. Karlsson, H., Larsson, P., Wold, A. E. & Rudin, A. Pattern of cytokine responses to gram-positive and gram-negative commensal bacteria is profoundly changed when monocytes differentiate into dendritic cells. Infect. Immun. 72, 2671-2678 (2004).
146. Mane, J. et al. A mixture of Lactobacillus plantarum CECT 7315 and CECT 7316 enhances systemic immunity in elderly subjects: a dose-response, double-blind, placebo-controlled, randomized pilot trial. Nutr. Hosp. 26, 228-235 (2011).
147. Bouwman, F. G. et al. 2D electrophoresis and multiplex immunoassay proteomic analysis of different body fluids and cellular components reveal known and novel markers for extended fasting. BMC Med. Genomics 4, 24 (2011).
148. Rimbach, G. et al. Dietary isoflavones in the prevention of cardiovascular disease: a molecular perspective. Food Chem. Toxicol. 46, 1308-1319 (2008).
149. Cheng, F. et al. A critical role for Stat3 signalling in immune tolerance. Immunity 19, 425-436 (2003).
150. Yang, X. O. et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282, 9358-9363 (2007).
151. Chaudhry, A. et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986-991 (2009).
152. Stritesky, G. L. et al. The transcription factor STAT3 is required for T helper 2 cell development. Immunity 34, 39-49 (2011).
153. de Roos, N. M. & Katan, M. B. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am. J. Clin. Nutr. 71, 405-411 (2000).
154. Szajewska, H., Ruszczynski, M. & Radzikowski, A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J. Pediatr. 149, 367-372 (2006).
155. Muller, M. & Kersten, S. Nutrigenomics: goals and strategies. Nature Rev. Genet. 4, 315-322 (2003).
156. Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65 (2010).
157. Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174-180 (2011).
158. Canani, R. B. et al. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 335, 340 (2007).
159. Snel, J. et al. Strain-specific immunomodulatory effects of Lactobacillus plantarum strains on birch-pollen-allergic subjects out of season. Clin. Exp. Allergy 41, 232-242 (2011).
160. Johansson, M. E. et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl Acad. Sci. USA 105, 15064-15069 (2008).
161. Walter, J. et al. Identification of Lactobacillus reuteri genes specifically induced in the mouse gastrointestinal tract. Appl. Environ. Microbiol. 69, 2044-2051 (2003).
162. Denou, E. et al. Gene expression of commensal Lactobacillus johnsonii strain NCC533 during in vitro growth and in the murine gut. J. Bacteriol. 189, 8109-8119 (2007). The first study to investigate a Lactobacillus sp. in situ transcriptome in the mouse intestine.
163. Willing, B. P., Antunes, L. C., Keeney, K. M., Ferreira, R. B. & Finlay, B. B. Harvesting the biological potential of the human gut microbiome. Bioessays 33, 414-418 (2011).
164. Zoetendal, E. G., Rajilic-Stojanovic, M. & de Vos, W. M. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605-1615 (2008).
165. Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105, 16731-16736 (2008).
166. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011).
167. Kunisawa, J. & Kiyono, H. Peaceful mutualism in the gut: revealing key commensal bacteria for the creation and maintenance of immunological homeostasis. Cell Host Microbe 9, 83-84 (2011).
168. Nelson, K. E. et al. A catalogue of reference genomes from the human microbiome. Science 328, 994-999 (2010).
169. Gloux, K. et al. Development of high-throughput phenotyping of metagenomic clones from the human gut microbiome for modulation of eukaryotic cell growth. Appl. Environ. Microbiol. 73, 3734-3737 (2007).
170. Lakhdari, O. et al. Functional metagenomics: a high throughput screening method to decipher microbiota-driven NF κB modulation in the human gut. PLoS ONE 5, e13092 (2010).
171. Corcoran, B. M., Stanton, C., Fitzgerald, G. & Ross, R. P. Life under stress: the probiotic stress response and how it may be manipulated. Curr. Pharm. Des. 14, 1382-1399 (2008).
172. Bron, P. A. & Kleerebezem, M. Engineering lactic acid bacteria for increased industrial functionality. Bioeng. Bugs 2, 1-8 (2011).
173. Abraham, C. & Medzhitov, R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 140, 1729-1737 (2011).